VINAY YALAMANCHI: Open Payments
NPI 1538503271 · BRIDGEWATER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,953 in 125 payments from 15 companies in 2025. Trend: 2023 $1,506 · 2024 $1,378 · 2025 $1,953
Food & beverage: $1,933Grant: $20
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 37 | $521 |
| Janssen Biotech, Inc. | 18 | $285 |
| ABBVIE INC. | 17 | $237 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $147 |
| PFIZER INC. | 9 | $138 |
| Ardelyx, Inc. | 7 | $127 |
| Lilly USA, LLC | 6 | $123 |
| Phathom Pharmaceuticals, Inc. | 9 | $118 |
| GENZYME CORPORATION | 4 | $90 |
| QOL Medical, LLC | 2 | $39 |
Products named: REZDIFFRA, TREMFYA, IBSRELA, OMVOH, RINVOQ, VOQUEZNA, XIFAXAN, DUPIXENT.
Industry payments across NJ — which companies pay providers there.
